Renal Trials in Asia-Pacific: Opportunities and Advancements October 29th, 2020

Join a conversation with George Clinical Drs. Adrian Liew and Muh Geot Wong covering renal issues particularly prevalent in the Asia-Pacific region. This webinar will discuss how treatment approaches should differ when implementing new global trials in this region, as well as economic hurdles that may impact diagnostic algorithms and standard of care decisions when considering an APAC trial.

Topics for the Conversation:

  • The potential of APAC countries for renal clinical trials.
  • Specific differences in treatment approaches that must be considered in the implementation of new global trials.
  • Potential challenges with participants.
  • The economic hurdles that can impact the way diagnostic algorithms and standard of care are implemented.
  • Unique aspects impacting renal trials in the region.
  • Geographic challenges/factors to consider when designing trials.
  • A recording of the webinar will be available for streaming after the event.


We hope to see you there.

The session will be streamed live on: October 29 at 8:00 AM ET (USA)

REGISTER TODAY

George Clinical's Leadership in Attendance

Dr. Liew’s research interests include glomerular diseases, peritoneal dialysis and diabetic kidney disease. He is a member of the Executive Committee of the ISN and chairs the ISN Oceania-Southeast Asia Regional Board. He serves as Senior Consultant Nephrologist and Director of The Kidney and Transplant Practice at Mount Elizabeth Novena Hospital, Singapore, and is a member of several KDIGO Guideline working groups.

Dr. Liew is responsible for the implementation of renal initiatives in Singapore and in the development of glomerular disease and peritoneal dialysis programs in Southeast Asia. In 2020, he became the only Singaporean and Southeast Asian to receive the John Mayer Award from the International Society for Peritoneal Dialysis, an award that honors individuals who have made significant contributions to the field of peritoneal dialysis. He chairs the Asian-Pacific Society of Nephrology Guideline working group on diabetic kidney disease and Dialysis Sub-group for the ISN Global Strategy for End-Stage Kidney Disease. He is also the national leader and global steering committee member for various multicentre clinical trials.

Dr. Wong’s research interest is in understanding the pathomechanism of kidney fibrosis and he has actively promoted the development of both clinical and pre-clinical research in delaying CKD progression in diabetic nephropathy, IgA nephropathy, and management of cardiovascular complications associated with CKD. He is a renal physician and Senior Staff Specialist at the Royal North Shore Hospital, Sydney; Senior clinical Lecturer of University of Sydney and University of NSW; and Senior Research Fellow, Renal & Metabolic Division for The George Institute and at the Kolling Institute.¬†

Dr. Wong currently serves as the Head of the Renal Clinical trial unit at the RNSH and Co-Chair of the Research Group for the Chronic and Complex Medicine Network for Northern Sydney Lower Health District (NSLHD). He is the Deputy Chair of the Oceania South East Asia Regional Board, International Society of Nephrology (ISN) transitioning to Chair in 2021. As a member of the Working Group for Clinical Practice Guidelines for Diabetic Nephropathy for the APCN he has a focus on lower and middle income countries. He has been invited as Vice-Chair of the Program Committee for the Asia Pacific Society of Nephrology (ASPN) 2021 in Thailand.

https://scholar.google.com/scholar?hl=en&as_sdt=0%2C43&q=muh+geot+wong&btnG=

Event Location

Zoom Webinar

Attending this event?

Meet with George Clinical! Contact us to schedule a time now.

    I agree to the handling of my personal information in accordance with the George Clinical privacy policy.

    Please input this code: captcha

    Add George Clinical to your network